Chemical Structure (Image 1)
Lansoprazole Tablet, Orally Disintegrating, Delayed Release
Product Images NDC 0093-3008
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 0093-3008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-01 (Image 2)
This is a chart showing the Mean Severity of Day Heartburn for evaluable patients over a period of 60 days. The severity is rated on a scale of 0 (no severity) to 3 (severe). The chart compares the results of three treatments over time: a placebo, 15 mg QD of Lansoprazole, and 30 mg QD of Lansoprazole.*
Figure-02 (Image 3)
This is a chart displaying the mean severity level of night heartburn for three different treatments: placebo, lansoprazole 15mg QD, and lansoprazole 30mg QD. The severity level ranges from 0 (none) to 3 (severe), with 1 being mild and 2 being moderate. The chart shows the severity level by study day for evaluable patients, with the x-axis representing days from the start of treatment.*
Carton 15 mg (Image 4)
Carton 30 mg (Image 5)
Lansoprazole is a type of medication available in orally disintegrating tablets, in a pack of 200 tablets with a count of 10 per sheet. The tablets are used to treat conditions related to excess stomach acid and are manufactured by the company ReVe. The text also includes various codes and numbers which may be related to the product's manufacture and distribution.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
